BioCentury
ARTICLE | Distillery Therapeutics

Cancer

December 5, 2017 7:29 PM UTC

Patient and mouse studies suggest inhibiting FBXO32 could help treat metastatic breast cancer. In patient tumor samples, FBXO32 expression was higher in invasive tumors than in non-invasive tumors. In...

BCIQ Target Profiles

F-box protein 32 (FBXO32)